Full Project 1: LSR Alters Metabolic Signaling to Drive Aggressive Breast Cancer Behaviors

完整项目 1:LSR 改变代谢信号以驱动侵袭性乳腺癌行为

基本信息

项目摘要

The North Carolina Central University (NCCU) and the Lineberger Comprehensive Cancer Center (LCCC) at the University of North Carolina Chapel Hill (UNC-CH) will continue their effective and mutually beneficial partnership focusing on African-American health disparities. During the past 13 years NCI funding has firmly established the Partnership building on complementary institutional strengths, conducting molecular and population-based cancer research and training of junior faculty and students. This Comprehensive Partnership to Advance Cancer Health Equity (CPACHE) application builds upon the foundation already established through the previous U54 funding to meet the challenge of disparities in cancer incidence and mortality in North Carolina and the US through cancer research, education and community outreach. Our goals are to: (1) strengthen cancer research capacity at NCCU providing NCCU scientists mentorship and collaborative opportunities to compete for NCI grantst; (2) enrich the capacity of NCCU and LCCC to further explore mechanisms underlying the disproportionate incidence of cancer mortality and morbidity between African Americans and Caucasian Americans, using both molecular and population-based approaches; (3) increase the number of NCCU scientists focused on cancer research as well as the education of minority undergraduate and graduate students in cancer research; (4) increase the faculty at the UNC LCCC focused on minority disparities research; and (5) create long-term collaborations between basic, public health, and translational scientists from NCCU and UNC LCCC. The strengths of each institution are uniquely positioned to overcome the weaknesses found in the other to achieve these priorities. Specific collaborative components of the proposal include: Two full and one pilot projects in community intervention and population science, one full and one pilot project in basic/translational cancer research in diseases with a higher incidence in African Americans, and 3 cores: Outreach, Research Education, and Histopathology. The partnership combines the expertise and resources of LCCC in population/public health sciences emphasizing disparities in North Carolina, genomics, cancer biology and cancer education and NCCU’s demonstrated interest and facilty with minority health disparities research particularly in Durham NC, the state-funded NCCU units that allow faculty release from teaching and the emphasis on reaching minority populations and developing the careers of , faculty and students. These complementary institutional strengths will assure that the Partnership builds the infrastructure necessary for a lasting collaborative research, effective community outreach and a substantial contribution to our understanding of minority disparities..
北卡罗来纳州中央大学(NCCU)和Lineberger综合 北卡罗来纳大学教堂山(UNC-CH)的癌症中心(LCCC)将继续 他们的有效和互惠互利的伙伴关系专注于非裔美国人健康 差异。在过去的13年中,NCI资金首先建立了合作伙伴关系 基于完整的机构优势,进行分子和基于人群 初级教师和学生的癌症研究和培训。这种全面的合作伙伴关系 Advance Cancer Health平等(CPACHE)应用程序已经建立在基础上 通过以前的U54资金建立,以应对癌症差异的挑战 北卡罗来纳州和美国的发病率和死亡率通过癌症研究,教育和 社区宣传。我们的目标是:(1)增强NCCU的癌症研究能力 为NCCU科学家提供精力和协作机会,以争夺NCI Grantst; (2)丰富了NCCU和LCCC进一步探索机制的能力 非洲裔美国人之间癌症死亡率和发病率的不成比例的事件 以及使用分子和基于人群的方法的高加索美国人; (3) 增加了专注于癌症研究的NCCU科学家的数量以及对 癌症研究的少数群体本科生和研究生; (4)增加教师 UNC LCCC专注于少数民族差异研究; (5)建立长期合作 在NCCU和UNC LCCC的基本,公共卫生和翻译科学家之间。这 每个机构的优势都具有独特的位置,以克服在 其他以实现这些优先事项。该提案的特定协作组成部分包括: 社区干预和人口科学领域的两个完整和一个试点项目,一个完整, 一个疾病基本/转化癌症研究的试点项目,较高的事件 非裔美国人和3个核心:外展,研究教育和组织病理学。这 合作伙伴关系结合了LCCC在人群/公共卫生科学中的专业知识和资源 强调北卡罗来纳州,基因组学,癌症生物学和癌症教育的分布以及 NCCU对少数族裔健康差异研究表现出兴趣和兴趣,尤其是 在北卡罗来纳州达勒姆(Durham NC)中 强调接触少数群体,并发展教职员工和学生的职业。 这些完整的机构优势将确保伙伴关系建立 持久协作研究,有效的社区外展和 对我们对少数分配的理解做出了重大贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jodie Michelle Fleming其他文献

Jodie Michelle Fleming的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jodie Michelle Fleming', 18)}}的其他基金

Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
项目 2 - 连接癌症差异和代谢状态的机制
  • 批准号:
    10204739
  • 财政年份:
    2017
  • 资助金额:
    $ 18.9万
  • 项目类别:
Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
项目 2 - 连接癌症差异和代谢状态的机制
  • 批准号:
    9977714
  • 财政年份:
    2017
  • 资助金额:
    $ 18.9万
  • 项目类别:
HGF signaling in African-American and Basal-like Breast Cancer
非裔美国人乳腺癌和基底样乳腺癌中的 HGF 信号传导
  • 批准号:
    8726349
  • 财政年份:
    2013
  • 资助金额:
    $ 18.9万
  • 项目类别:
HGF signaling in African-American and Basal-like Breast Cancer
非裔美国人乳腺癌和基底样乳腺癌中的 HGF 信号传导
  • 批准号:
    8491064
  • 财政年份:
    2013
  • 资助金额:
    $ 18.9万
  • 项目类别:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
开发治疗基底样乳腺癌的新型靶向疗法
  • 批准号:
    8337127
  • 财政年份:
    2012
  • 资助金额:
    $ 18.9万
  • 项目类别:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
开发治疗基底样乳腺癌的新型靶向疗法
  • 批准号:
    8731643
  • 财政年份:
    2012
  • 资助金额:
    $ 18.9万
  • 项目类别:
Development of a novel targeted-therapy for treatment of basal-like breast cancer
开发治疗基底样乳腺癌的新型靶向疗法
  • 批准号:
    8551659
  • 财政年份:
    2012
  • 资助金额:
    $ 18.9万
  • 项目类别:
Full Project 1: LSR Alters Metabolic Signaling to Drive Aggressive Breast Cancer Behaviors
完整项目 1:LSR 改变代谢信号以驱动侵袭性乳腺癌行为
  • 批准号:
    9050348
  • 财政年份:
    2010
  • 资助金额:
    $ 18.9万
  • 项目类别:
Project 2 - Mechanisms linking Cancer Disparities and Metabolic Status
项目 2 - 连接癌症差异和代谢状态的机制
  • 批准号:
    9750532
  • 财政年份:
  • 资助金额:
    $ 18.9万
  • 项目类别:
Full Project 4: Molecular Pathways to Breast Cancer Mortality among African American and White Women
完整项目 4:非裔美国和白人女性乳腺癌死亡率的分子途径
  • 批准号:
    10004337
  • 财政年份:
  • 资助金额:
    $ 18.9万
  • 项目类别:

相似海外基金

Project: Survivorship Care Physical Activity Initiative to Improve Disparities in HRQoL for Prostate Cancer Survivors (RELate Study)
项目:旨在改善前列腺癌幸存者 HRQoL 差异的生存护理体力活动计划(RELate 研究)
  • 批准号:
    10911646
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
Determining the impact of ancestry on oropharyngeal cancer biology and treatment response.
确定血统对口咽癌生物学和治疗反应的影响。
  • 批准号:
    10562456
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
New Hardware and Software Developments for Improving Prostate Metabolic MR Imaging
用于改善前列腺代谢 MR 成像的新硬件和软件开发
  • 批准号:
    10680043
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry
社区采用分子方法进行早期筛查和诊断,通过对非洲裔人群癌症的持续护理来促进公平结果
  • 批准号:
    10754038
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
Project 3: Credentialing CDK 4/6 inhibitors used with radiation as an effective treatment strategy in locally advanced ER+ and TNBC
项目 3:认证 CDK 4/6 抑制剂与放射结合使用作为局部晚期 ER 和 TNBC 的有效治疗策略
  • 批准号:
    10554474
  • 财政年份:
    2023
  • 资助金额:
    $ 18.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了